Paclitaxel 30

Paclitaxel 30 mg Injection
Paclitaxel 30 mg Injection is a well-established anticancer (antineoplastic) medication used in the treatment of various solid tumors. It belongs to the taxane class of chemotherapy drugs and works by inhibiting cancer cell division, thereby slowing or stopping tumor growth. Paclitaxel is widely used in oncology treatment protocols worldwide.
Product Details
Generic Name: Paclitaxel
Strength: 30 mg
Dosage Form: Injection (Sterile solution for infusion)
Route of Administration: Intravenous (IV infusion)
Therapeutic Class: Antineoplastic Agent (Taxane)
Indications
Paclitaxel 30 mg Injection is indicated for the treatment of:
Breast cancer
Ovarian cancer
Non-small cell lung cancer
Kaposi’s sarcoma
Head and neck cancers
Other solid tumors as prescribed by an oncologist
Mechanism of Action
Paclitaxel promotes the stabilization of microtubules and prevents their breakdown during cell division. This disrupts the normal mitotic process, leading to arrest of cancer cell growth and eventual cell death.
Key Benefits
Proven efficacy against multiple solid tumors
Widely used in combination chemotherapy regimens
Reliable and well-researched oncology drug
Suitable for global oncology treatment standards
Dosage & Administration
Dosage is determined based on body surface area (BSA), disease condition, and treatment protocol. Paclitaxel should be administered only under strict medical supervision by qualified healthcare professionals.
Storage Conditions
Store below 25°C
Protect from light
Do not freeze
Keep vial in original packaging until use
Precautions
For hospital and oncology clinic use only
Monitor blood counts regularly during therapy
Premedication may be required to reduce hypersensitivity reactions
Regulatory Status
Prescription Drug (Rx only)